Bessemer Group Inc Liquidia Corp Transaction History
Bessemer Group Inc
- $61.6 Billion
- Q2 2025
A detailed history of Bessemer Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Bessemer Group Inc holds 80 shares of LQDA stock, worth $1,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 80
-0.0%
Holding current value
$1,960
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
211Shares Held
47.4MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$104 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$104 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$88.1 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$73.5 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$60.7 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.58B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...